Innovative Medicine
healthcare areas

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Innovative Medicine /
    2. Immunology /
    3. Autoantibody diseases /
    4. Rare autoantibody

    Rare autoantibody

    Johnson & Johnson is committed to tirelessly pushing the boundaries of research to help develop innovative and transformational approaches to rare autoantibody-driven diseases, building on the ever-evolving understanding of the immune system.

    Disease areas

    Neuroscience
    June 25, 2025

    Chronic inflammatory demyelinating polyneuropathy

    Learn more
    Neuroscience
    June 25, 2025

    Myasthenia gravis

    Learn more
    Rare autoantibody
    June 25, 2025

    Warm autoimmune hemolytic anemia

    Learn more
    JJ_Photo_CorkFacility_1879.jpg

    Newsroom

    See the latest rare autoantibody news by visiting our newsroom.
    Learn more

    Featured resources

    Our work

    What is wAIHA?

    Read more
    In the news

    Rare autoantibody diseases: an innovative targeted pathway

    Read more
    Our people

    Patient Perspective: Karen Jones on the wAIHA patient experience and a path forward

    Read more
    Our people

    Listening and learning: Structuring clinical trials for patients living with warm autoimmune hemolytic anemia

    Read more
    Our work

    What is rare disease

    Read more
    Our people

    “I couldn’t speak, walk or sit.” Inside dermatomyositis, a rare autoimmune disease that attacks the muscles

    Read more
    Our work
    June 25, 2025

    Warm autoimmune hemolytic anemia (wAIHA)

    Read more